{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:34:13Z","timestamp":1766486053851,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","award":["15397","26\/9\/18"],"award-info":[{"award-number":["15397","26\/9\/18"]}],"id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajo.2022.11.015","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T15:49:13Z","timestamp":1669045753000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study"],"prefix":"10.1016","volume":"248","author":[{"given":"Andrea","family":"Spini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-1778","authenticated-orcid":false,"given":"Sabrina","family":"Giometto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-0381","authenticated-orcid":false,"given":"Matteo","family":"Posarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Ziche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-1717","authenticated-orcid":false,"given":"Gian Marco","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-5902","authenticated-orcid":false,"given":"Ersilia","family":"Lucenteforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahyar","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2022.11.015_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2017.0059","article-title":"Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery","volume":"135","author":"Eadie","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.11.015_bib0002","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bjophthalmol-2015-307595","article-title":"Changes in intraocular pressure in study and fellow eyes in the IVAN trial","volume":"100","author":"Foss","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.11.015_bib0003","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/jamaophthalmol.2021.4395","article-title":"Intraocular pressure-related events after anti-vascular endothelial growth factor therapy for macular edema due to central retinal vein occlusion or hemiretinal vein occlusion: SCORE2 report 16 on a secondary analysis of a randomized clinical trial","volume":"139","author":"Aref","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2022.11.015_bib0004","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2013.11.029","article-title":"Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials","volume":"121","author":"Bakri","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2022.11.015_bib0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/IJG.0000000000001894","article-title":"Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations","volume":"30","author":"Levin","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2022.11.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100954","article-title":"VEGFR1 signaling in retinal angiogenesis and microinflammation","volume":"84","author":"Uemura","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2022.11.015_bib0007","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.preteyeres.2018.10.006","article-title":"The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases","volume":"69","author":"Van Bergen","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.11.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267088","article-title":"Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: a nationwide population-based cohort study","volume":"17","author":"Chang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2022.11.015_bib0009","first-page":"1","article-title":"Intraocular pressure decreases in eyes with glaucoma-related diagnoses after conversion to aflibercept for treatment-resistant age-related macular degeneration","author":"Ramsey","year":"2021","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ajo.2022.11.015_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpt.2476","article-title":"From inception to ConcePTION: genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding","volume":"111","author":"Thurin","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2022.11.015_bib0011","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40264-018-0732-5","article-title":"The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand?","volume":"42","author":"Trifir\u00f2","year":"2019","journal-title":"Drug Saf"},{"issue":"4 Suppl 2","key":"10.1016\/j.ajo.2022.11.015_bib0012","first-page":"37","article-title":"A systematic review of case-identification algorithms based on italian healthcare administrative databases for three relevant diseases of the cardiovascular system: acute myocardial infarction, ischemic heart disease, and stroke","volume":"43","author":"Hyeraci","year":"2019","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ajo.2022.11.015_bib0013","unstructured":"Ozurdex product information. Accessed August 2, 2022. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ozurdex-epar-product-information_en.pdf"},{"key":"10.1016\/j.ajo.2022.11.015_bib0014","article-title":"Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)","author":"Paciullo","year":"2022","journal-title":"Blood Transfus"},{"issue":"9","key":"10.1016\/j.ajo.2022.11.015_bib0015","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ophtha.2015.04.018","article-title":"Intraocular pressure in patients with neovascular age-related macular degeneration receiving intravitreal aflibercept or ranibizumab","volume":"122","author":"Freund","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2022.11.015_bib0016","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.oret.2020.06.020","article-title":"Intraocular pressure changes and vascular endothelial growth factor inhibitor use in various retinal diseases: long-term outcomes in routine clinical practice: data from the Fight Retinal Blindness! Registry","volume":"4","author":"Gabrielle","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.ajo.2022.11.015_bib0017","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ophtha.2017.11.027","article-title":"The real-world effect of intravitreous anti\u2013vascular endothelial growth factor drugs on intraocular pressure: an analysis using the IRIS Registry","volume":"125","author":"Atchison","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2022.11.015_bib0018","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jcmm.12151","article-title":"Inhibition of placental growth factor improves surgical outcome of glaucoma surgery","volume":"17","author":"Van Bergen","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.ajo.2022.11.015_bib0019","first-page":"517","article-title":"Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic","volume":"76","author":"Ziche","year":"1997","journal-title":"Lab Invest"},{"issue":"8","key":"10.1016\/j.ajo.2022.11.015_bib0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.11.015_bib0021","doi-asserted-by":"crossref","first-page":"39301","DOI":"10.1038\/srep39301","article-title":"Sustained elevation of intraocular pressure associated with intravitreal administration of anti-vascular endothelial growth factor: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajo.2022.11.015_bib0022","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","article-title":"Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans","volume":"154","author":"Krohne","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.11.015_bib0023","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1167\/iovs.10-6431","article-title":"Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2022.11.015_bib0024","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1177\/1120672119885045","article-title":"Use of anti-vascular endothelial growth factor drugs for eye disease in Tuscany: development and test of indicators of treatment intensity","volume":"30","author":"Virgili","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2022.11.015_bib0025","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00417-019-04404-0","article-title":"Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study","volume":"257","author":"Augsburger","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422004408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422004408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:51:56Z","timestamp":1757598716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422004408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"alternative-id":["S0002939422004408"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.11.015","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}